These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 28213912)

  • 21. Diagnostic delay and prognosis in primary central nervous system lymphoma compared with glioblastoma multiforme.
    Cerqua R; Balestrini S; Perozzi C; Cameriere V; Renzi S; Lagalla G; Mancini G; Montanari M; Leoni P; Scerrati M; Iacoangeli M; Silvestrini M; Luzzi S; Provinciali L
    Neurol Sci; 2016 Jan; 37(1):23-29. PubMed ID: 26233232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-dose methotrexate is beneficial in parenchymal brain masses of uncertain origin suspicious for primary CNS lymphoma.
    Kiewe P; Loddenkemper C; Anagnostopoulos I; Reinwald M; Thiel E; Korfel A
    Neuro Oncol; 2007 Apr; 9(2):96-102. PubMed ID: 17301290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of preoperative corticosteroid treatment on rate of diagnostic surgeries in primary central nervous system lymphoma: a multicenter retrospective study.
    Scheichel F; Marhold F; Pinggera D; Kiesel B; Rossmann T; Popadic B; Woehrer A; Weber M; Kitzwoegerer M; Geissler K; Dopita A; Oberndorfer S; Pfisterer W; Freyschlag CF; Widhalm G; Ungersboeck K; Roessler K
    BMC Cancer; 2021 Jun; 21(1):754. PubMed ID: 34187419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Central nervous system lymphoma: patterns of incidence in Indian population and effect of steroids on stereotactic biopsy yield.
    Manoj N; Arivazhagan A; Mahadevan A; Bhat DI; Arvinda HR; Devi BI; Sampath S; Chandramouli BA
    Neurol India; 2014; 62(1):19-25. PubMed ID: 24608449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methylated markers accurately distinguish primary central nervous system lymphomas (PCNSL) from other CNS tumors.
    Downs BM; Ding W; Cope LM; Umbricht CB; Li W; He H; Ke X; Holdhoff M; Bettegowda C; Tao W; Sukumar S
    Clin Epigenetics; 2021 May; 13(1):104. PubMed ID: 33952317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extensive subpial cortical demyelination is specific to multiple sclerosis.
    Junker A; Wozniak J; Voigt D; Scheidt U; Antel J; Wegner C; Brück W; Stadelmann C
    Brain Pathol; 2020 May; 30(3):641-652. PubMed ID: 31916298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Primary CNS lymphomas. Morphology and diagnosis].
    Feiden W; Milutinovic S
    Pathologe; 2002 Jul; 23(4):284-91. PubMed ID: 12185781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis of primary cerebral lymphomas: possible value of PCR testing in equivocal cases requiring rebiopsy.
    Shaw A; Iyer V; Rooney N; Wragg R; Waits P; Roberts E; Haynes HR; Kurian KM
    Br J Neurosurg; 2014 Apr; 28(2):214-9. PubMed ID: 23875881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinguishing primary central nervous system lymphoma from other central nervous system diseases: a neurosurgical perspective on diagnostic dilemmas and approaches.
    Hunt MA; Jahnke K; Murillo TP; Neuwelt EA
    Neurosurg Focus; 2006 Nov; 21(5):E3. PubMed ID: 17134119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term follow-up of vanishing tumors in the brain: how should a lesion mimicking primary CNS lymphoma be managed?
    Okita Y; Narita Y; Miyakita Y; Ohno M; Fukushima S; Maeshima A; Kayama T; Shibui S
    Clin Neurol Neurosurg; 2012 Nov; 114(9):1217-21. PubMed ID: 22445618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lesion development in Marburg's type of acute multiple sclerosis: from inflammation to demyelination.
    Bitsch A; Wegener C; da Costa C; Bunkowski S; Reimers CD; Prange HW; Brück W
    Mult Scler; 1999 Jun; 5(3):138-46. PubMed ID: 10408713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Could Cerebral Inflammatory Lesions be the Cellular Origin of Primary Central Nervous System Lymphoma?
    Ma J; Zhang J; Chen T; Bai H; Yu X; Wang H
    J Craniofac Surg; 2024 Jun; 35(4):1209-1213. PubMed ID: 38709059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary central nervous system lymphoma.
    Bhagavathi S; Wilson JD
    Arch Pathol Lab Med; 2008 Nov; 132(11):1830-4. PubMed ID: 18976024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Intraocular non-Hodgkin's lymphoma and its therapy-- a case series of ten patients].
    Siepmann K; Rohrbach JM; Duncker G; Zierhut M
    Klin Monbl Augenheilkd; 2004 Apr; 221(4):266-72. PubMed ID: 15118956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CSF neopterin level as a diagnostic marker in primary central nervous system lymphoma.
    Viaccoz A; Ducray F; Tholance Y; Barcelos GK; Thomas-Maisonneuve L; Ghesquières H; Meyronet D; Quadrio I; Cartalat-Carel S; Louis-Tisserand G; Jouanneau E; Guyotat J; Honnorat J; Perret-Liaudet A
    Neuro Oncol; 2015 Nov; 17(11):1497-503. PubMed ID: 26014047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary CNS Lymphoma vs. Tumefactive Multiple Sclerosis: A Diagnostic Challenge.
    Naeem SB; Niazi F; Baig A; Sadiq H; Sattar M
    J Coll Physicians Surg Pak; 2018 Jan; 28(1):66-68. PubMed ID: 29290197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A diagnostic challenge of primary Central nervous system lymphoma: from the eyes to the brain.
    Su M; Huang D; Sun L; Dong Z; Wu L; Yu S
    Int J Neurosci; 2021 Nov; 131(11):1139-1145. PubMed ID: 32449877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary Central Nervous System Lymphoma with Associated Demyelination and Creutzfeldt Astrocytes.
    Achi HE; Lally JE; Riascos RF; Zhu JJ; Tandon N; Esquenazi Y; Bhattacharjee MB; Ballester LY
    Ann Clin Lab Sci; 2018 Jul; 48(4):534-537. PubMed ID: 30143499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LCK expression is a potential biomarker for distinguishing primary central nervous system lymphoma from glioblastoma multiforme.
    Ge L; Xu L; Lu S; Yan H
    FEBS Open Bio; 2020 May; 10(5):904-911. PubMed ID: 32237064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CSF interleukin 6 is a useful marker to distinguish pseudotumoral CNS inflammatory diseases from primary CNS lymphoma.
    Ungureanu A; Le Garff-Tavernier M; Costopoulos M; Parratte T; Brinet A; Durand H; Gaultier C; Hurstel R; Alamome I; Sellal F; Ahle G
    J Neurol; 2021 Aug; 268(8):2890-2894. PubMed ID: 33609156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.